richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
Published 6 years ago • 47 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:14
richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
-
1:47
richard kim, md determines whether checkpoint inhibitors combine with regorafenib for hcc treatment
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
1:33
richard kim, md, offers analysis of the rainfall study in metastatic gastric & ge junction cancer
-
1:34
richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
-
49:38
drop acid: understanding uric acid and its impact on health with dr. david perlmutter
-
10:48
acid reflux can cause vertigo? the horrifying connection...
-
7:24
#aflibercept | uses, dosage, side effects & mechanism | eylea
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
0:58
managing colorectal cancer in patients who progress on regorafenib
-
9:34
regorafenib in colorectal cancer
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
0:47
dr. richards on parp inhibition in pancreatic cancer
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
3:10
regorafenib in refractory biliary tract cancer
-
1:28
health awareness: can colorectal cancer be cured?
-
0:39
how does diet affect my risk of colorectal cancer? - dr. lisa boardman
-
2:38
robert mayer, md, on gastrointestinal cancers